Generation Bio Company Leadership

GBIO Stock  USD 4.61  0.41  9.76%   
Generation Bio's insiders are aggressively buying. The analysis of the overall insider sentiment regarding Generation Bio Co suggests that virtually all insiders are extremely bullish. Generation Bio employs about 115 people. The company is managed by 15 executives with a total tenure of roughly 269 years, averaging almost 17.0 years of service per executive, having 7.67 employees per reported executive.

Insider Sentiment 100

 Aggressively Buying

 
Selling
 
Buying

Latest Trades

2025-01-13Anthony G QuinnAcquired 8500 @ 9.7View
2025-01-10Anthony G QuinnAcquired 12579 @ 9.6View
Monitoring Generation Bio's insider sentiment can offer insights into its future performance, as insiders often have access to more information about their company's operations, financial health, and upcoming initiatives than the general public. However, it's essential to note that insider trading is regulated by securities laws, and insiders are required to disclose their trades publicly to ensure transparency and prevent unfair advantages based on non-public information.
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Generation Bio Co. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product.

Generation Bio's Workforce Through the Years

Please note that employee historical analysis has become an increasingly important factor for investors assessing the risk associated with Generation Bio's future performance. Based on our forecasts, it is anticipated that Generation will maintain a workforce of about 120 employees by August 2025.
 
Covid

Generation Bio Management Team Effectiveness

The company has return on total asset (ROA) of (0.1897) % which means that it has lost $0.1897 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.7006) %, meaning that it created substantial loss on money invested by shareholders. Generation Bio's management efficiency ratios could be used to measure how well Generation Bio manages its routine affairs as well as how well it operates its assets and liabilities. As of the 25th of July 2025, Return On Tangible Assets is likely to drop to -0.6. In addition to that, Return On Capital Employed is likely to drop to -0.76. At this time, Generation Bio's Total Assets are very stable compared to the past year. As of the 25th of July 2025, Non Current Assets Total is likely to grow to about 60.4 M, while Net Tangible Assets are likely to drop about 174.3 M.
As of the 25th of July 2025, Common Stock Shares Outstanding is likely to drop to about 53.2 M. In addition to that, Net Loss is likely to drop to about (129.1 M)

Generation Bio Workforce Comparison

Generation Bio Co is rated # 5 in number of employees category among its peers. The total workforce of Health Care industry is currently estimated at about 1,340. Generation Bio holds roughly 115 in number of employees claiming about 9% of equities under Health Care industry.
The company has Profit Margin (PM) of (2.93) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (1.77) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $1.77.

Generation Bio Insider Trading History

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Generation Bio insiders, such as employees or executives, is commonly permitted as long as it does not rely on Generation Bio's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases, Generation Bio insiders must file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
 
Covid
Buy/Sell Ratio# Purchases Trades# Sales TradesTotal Shares PurchasedTotal Shares Sold
2025-09-01
0.5
5
10
 11,946 
 15,455 
2025-06-01
1.4
14
10
 281,947 
 15,456 
2025-03-01
1.2
12
10
 2,232,778 
 16,089 
2024-12-01
0.5
7
14
 16,381 
 21,193 
2024-09-01
0.4667
7
15
 16,381 
 27,912 
2024-06-01
1.1429
16
14
 566,422 
 34,181 
2024-03-01
0.6389
23
36
 1,399,662 
 182,074 
2023-12-01
1.3125
21
16
 1,236,584 
 85,150 
2023-09-01
0.4444
8
18
 64,783 
 90,628 
2023-06-01
1.2
18
15
 447,085 
 82,382 
2023-03-01
1.3529
23
17
 790,191 
 89,159 
2022-12-01
0.4667
7
15
 61,440 
 85,907 
2022-09-01
1.1
11
10
 228,916 
 81,496 
2022-03-01
2.6
13
5
 1,396,919 
 289,514 
2021-12-01
1.0
1
1
 72,837 
 72,837 
2021-09-01
0.1333
6
45
 17,018 
 1,566,208 
2021-06-01
0.2088
19
91
 151,072 
 2,182,870 
2021-03-01
0.451
23
51
 919,041 
 1,471,302 
2020-12-01
0.3
3
10
 113,341 
 1,297,500 
2020-09-01
2.0
2
1
 392,560 
 62,560 
2020-06-01
0.5088
29
57
 32,380,741 
 60,214,714 

Generation Bio Notable Stakeholders

A Generation Bio stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Generation Bio often face trade-offs trying to please all of them. Generation Bio's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Generation Bio's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
Caitlin MBASenior DevelopmentProfile
Robert KotinCoFounder AdvisorProfile
Sara BestenChief OfficerProfile
Tracy ZimmermannChief OfficerProfile
Phillip SamayoaChief OfficerProfile
Jasmin TowerChief OfficerProfile
MBA MDChief OfficerProfile
Cameron MDCEO and PresidentProfile
MD MBAChief OfficerProfile
Esq JDChief OfficerProfile
Yalonda JDChief SecretaryProfile
Mark AngelinoCoFounderProfile
Kevin ConwayChief OfficerProfile
Matthew StantonChief OfficerProfile
MS MBAChief OfficerProfile

About Generation Bio Management Performance

The success or failure of an entity such as Generation Bio often depends on how effective the management is. Generation Bio management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Generation management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Generation management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Last ReportedProjected for Next Year
Return On Tangible Assets(0.57)(0.60)
Return On Capital Employed(0.73)(0.76)
Return On Assets(0.57)(0.60)
Return On Equity(1.53)(1.45)

Generation Bio Workforce Analysis

Traditionally, organizations such as Generation Bio use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Generation Bio within its industry.

Generation Bio Manpower Efficiency

Return on Generation Bio Manpower

Revenue Per Employee173K
Revenue Per Executive1.3M
Net Loss Per Employee1.1M
Net Loss Per Executive8.8M
Working Capital Per Employee1.4M
Working Capital Per Executive10.5M
When determining whether Generation Bio offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Generation Bio's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Generation Bio Co Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Generation Bio Co Stock:
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Generation Bio Co. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product.
You can also try the Transaction History module to view history of all your transactions and understand their impact on performance.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Generation Bio. If investors know Generation will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Generation Bio listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(10.80)
Revenue Per Share
3.678
Quarterly Revenue Growth
1.149
Return On Assets
(0.19)
Return On Equity
(0.70)
The market value of Generation Bio is measured differently than its book value, which is the value of Generation that is recorded on the company's balance sheet. Investors also form their own opinion of Generation Bio's value that differs from its market value or its book value, called intrinsic value, which is Generation Bio's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Generation Bio's market value can be influenced by many factors that don't directly affect Generation Bio's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Generation Bio's value and its price as these two are different measures arrived at by different means. Investors typically determine if Generation Bio is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Generation Bio's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.